![Darlene Noci](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Darlene Noci
Keine laufenden Positionen mehr
Profil
Darlene Noci is the founder of Noci Strategic Consulting LLC, founded in 2018.
Former jobs include Head-Regulatory Affairs at AVEO Pharmaceuticals, Inc., VP-Regulatory Affairs & Quality Assurance at X4 Pharmaceuticals, Inc. from 2016 to 2018, Principal at EMD Serono, Inc. from 2014 to 2016, and Chief Development Officer at Nuvalent, Inc. from 2022 to 2026.
Education includes graduate studies at Harvard University and undergraduate studies at Adelphi University.
Ehemalige bekannte Positionen von Darlene Noci
| Unternehmen | Position | Ende |
|---|---|---|
| NUVALENT, INC. | General Counsel | 20.07.2022 |
| X4 PHARMACEUTICALS, INC. | General Counsel | 01.05.2018 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | 01.01.2016 |
Noci Strategic Consulting LLC | Gründer | - |
| AVEO PHARMACEUTICALS, INC. | General Counsel | - |
Ausbildung von Darlene Noci
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
56
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adelphi University
 Adelphi University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Noci Strategic Consulting LLC |
